Others showed that in mice with NASH, supplementation of sodium butyrate caused increased expression of insulin receptor in the liver, leading to improved liver insulin sensitivity and hepatic steatosis41. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.